Production of icaADBC-encoded polysaccharide intercellular adhesin and therapeutic failure in pediatric patients with staphylococcal device-related infections

Staphylococci inhabit the skin and mucous membranes of animals and humans. Due to the ability to produce biofilm, they are also a common cause of device-associated infections [1–4]. Biofilm formation capacity is associated with antimicrobial resistance, and considered widely as a virulence factor. Invasive isolates are more prone to produce biofilm than carriage isolates of healthy individuals [5, 6]. Staphylococcus epidermidis was the first species to be described as a biofilm producer; however, the same ability is encountered in S. aureus and other coagulase-negative Staphylococcus species [7, 8].

The principal component of biofilm is a polysaccharide intercellular adhesin {PIA} [9, 10]. PIA is composed of a beta-1,6-N-acetylglucosamine polymer synthesized by an enzyme codified by the ica operon found on the bacterial chromosome, that includes a regulating element of four genes (A, B, C, and D), and a transposable element, IS256 [11]. It is known that the A gene codifies the N-acetylglucosamyl transferase enzyme responsible for synthesizing PIA. This enzyme is not very active in vitro, but co-expression of the D gene increases the activity. IcaB is the deacetylase responsible for the de-acetylation of mature PIA and the transmembrane protein IcaC seems to be involved in externalization and elongation of the growing polysaccharide [9, 12].

The expression of the icaADBC genes is controlled by a complex variety of conditions and factors; one of them is the excision or insertion of the bacterial sequence element IS256 at various locations on the operon. The molecular basis for the regulation process is still unclear; however, the insertion element is definitely responsible for up to 33% of the activated portion of the operon that allows its expression [1, 10, 13, 14]. Other regulator genes (RsbU, σ^B, Tca-R, agr, sarA) for PIA production have also been reported [15].

Biofilm production usually occurs in two steps, 1) the initial step of adhesion to the surface, facilitated by adhesive polysaccharides and/or a polysaccharide with multiple proteins (including autolysins), and 2) the accumulation of cells due to PIA production, synthesized after activation of the ica operon [9]. Initial findings assumed that the presence of icaADBC genes will contribute to the persistence of infection and therapeutic failure in presence of a medical device. Some authors have tried to establish the presence of the AD genes as a prognosis biomarker in device associated infections [8, 16]. Many other environmental conditions and the phenotype of the Staphylococcus isolate also participate in the regulation of biofilm production [17]. By understanding the different mechanisms of biofilm production it will be possible to support the development of therapeutic strategies [5].

The objective of this study was to describe the association between biofilm production, the presence of icaADBC genes, the bacterial insertion sequence IS256 and therapeutic failure, in isolates from patients with medical device-related infections.

Clinical staphylococci isolates were collected prospectively from hospitalized patients with a staphylococcal medical device-related infection from September 2002 to July 2003. Isolates were obtained from blood, cerebrospinal fluid and peritoneal fluid. The protocol was approved by the Institutional Review Board. Patient's data were obtained from clinical records. Infection was defined in accordance with internationally proposed criteria [18].

Empirical antimicrobial treatment was prescribed for all patients, and was modified according to susceptibility patterns.

During the study period, one hundred isolates from patients with diagnosis of device-related infections were included. The episodes were divided in 40 CVC-related bacteremias, 32 ependymitis, and 28 peritonitis. S. epidermidis was isolated in 45 episodes, S. aureus in 39 and diverse coagulase negative Staphylococcus (CoNS)non-epidermidis in 16 (S. hominis, S. haemolyticus, S. lugdunensis, S. auricularis, S. warnerii and S. sciurii). 33% of the isolates were oxacillin-resistant, 31% were resistant to amikacin, 26% to norfloxacin and 0% to vancomycin. According to the PFGE results, all the strains included corresponded to a different genotype.

Biofilm production was confirmed in 22 strains by the Christensen assay, of these, 19 had a positive phenotype on the CRA plates. IcaADBC genes and the bacterial insertion sequence IS256 were detected in most of the strains, except for two strains of S. auricularis, one S. warnerii and one S. sciurii. 73.77% of CoNS and 79.5% of S. aureus isolates harbored the icaD gene; icaA, icaB and icaC genes were present in 27.8%, 21.3% and 9.8% of CoNS isolates (Table 2, figure 1). Only 4/39 S. aureus isolates were positive for icaA+IcaD genes but none for the bacterial insertion sequence. IS256-A+ IS256-D genes were detected in 21/45 S. epidermidis and 6/16 non-epidermidis CoNS. (figure 2, figure 3).

Microorganism	No. isolates	IcaA	IcaB	IcaC	IcaD	IcaA+ IcaD	IS256-A/IS256-D
S. epidermidis	45	23	11	4	39	22	21
S. aureus	39	4	0	0	31	4	0
S. hominis	6	4	0	0	6	4	3
S. haemolyticus	4	1	1	1	2	2	2
S. lugdunensis	2	1	1	1	1	1	1
S. auricularis	2	0	0	0	0	0	0
S. warnerii	1	0	0	0	0	0	0
S. sciurii	1	0	0	0	0	0	0

Biofilm production has been clearly linked to infections in the presence of foreign bodies for various decades [26], it has been demonstrated in vivo tests with laboratory animals and in vitro, that biofilm hampered thorough penetration of the antimicrobial and the concentrations require to eradicate biofilm-producing strains are higher than those required to eradicate strains that did not produce biofilm [27, 28].

In this study, as reported by other authors, it was found that the genes of the Ica operon frequently appeared in strains of Staphylococcus epidermidis [4, 6, 29]. The number of S. aureus isolates with a positive biofilm phenotype or producing biofilm was low (4/39), and in none of them the bacterial insertion element IS256 was present. Experimental studies have also shown that biofilm formation is possible in icaADBC operon S. aureus mutants [30], but we did not find S. aureus negative for the operon that was a biofilm producer. S. epidermidis strains with the genetic determinant for biofilm formation were clearly associated to a high risk of therapeutic failure, which was not corroborated with non-epidermidis CoNS and S. aureus, perhaps due to a smaller number of collected isolates.

As previously stated, adhesion to the plastic device could be a factor linked to weaker expression of symptoms of infection, due to the existence of a smaller number of circulating bacteria, most of them remaining inside the catheter. This mild presentation could support the non-standard recommendation to preserve the medical device in patients with bacteremia. This is necessary in some cases due to the critical condition of the patient. However, the risk of failure to proper antimicrobial treatment is so high, that this conduct should be avoided and the CVC removed as soon as possible, even if a negative icaA +IcaD isolate is detected.

The present work has several limitations. Infections included are difficult to compare to elicit general recommendations, in particular for the ependymitis and peritonitis episodes. The ica operon genes have been widely described in Staphylococcus epidermidis and Staphylococcus aureus, several authors have found similarity in other CoNs species [6, 7] but results cannot be extended to all pathogenic species. Recently biofilm formation has been described in detail in S. haemolyticus isolates [31]. Phenotypic variation as well as clonal lineage must be included in future studies to develop alternative therapeutic strategies.

The presence of icaA/D genes along with the sequence element IS256 was associated with therapeutic failure in most CoNS infections, even though its absence in S. aureus isolates does not ensure therapeutic success.